FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bogusz Patricia 		2. Issuer Name and Ticker or Trading Symbol

BioScrip, Inc. [ BIOS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Vice President, Finance
(Last)          (First)          (Middle)

100 CLEARBROOK ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/14/2012
(Street)

ELMSFORD, NY 10523
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, Par Value $0.0001 Per Share   5/14/2012     M    5000   A $6.49   8028   D    
Common Stock, Par Value $0.0001 Per Share   5/14/2012     M    9000   A $2.47   17028   D    
Common Stock, Par Value $0.0001 Per Share   5/14/2012     S    14000   (2) D $7.52   3028   D    
Common Stock, $.0001 Par Value   (3)                7875   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option   $6.49   5/14/2012     M         5000    10/24/2006   (1) 10/24/2015   Common Stock, $.0001 Par Value   5000   $0   0   D    
Employee Stock Option   $2.47   5/14/2012     M         9000    11/1/2007   (1) 11/1/2016   Common Stock, $.0001 Par Value   9000   $0   0   D    
Employee Stock Option   $6.52                    4/29/2009   (1) 4/29/2018   Common Stock, $.0001 Par Value   19687     19687   D    
Employee Stock Option   $2.73                    4/28/2010   (1) 4/28/2019   Common Stock, $.0001 Par Value   20000     20000   D    
Employee Stock Option   $6.46                    7/27/2011   (1) 7/27/2020   Common Stock, $.0001 Par Value   10000     10000   D    
Employee Stock Option   $4.24                    3/1/2012   (1) 3/1/2021   Common Stock, $.0001 Par Value   20000     20000   D    
Employee Stock Option   $4.42                    4/26/2012   4/26/2021   Common Stock, $.0001 Par Value   50000     50000   D    
Employee Stock Option   $6.62                    3/8/2013   3/8/2022   Common Stock, $.0001 Par Value   100000     100000   D    

Explanation of Responses:
( 1)  Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
( 2)  The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.51 to $7.59 inclusive. The reporting person undertakes to provide to BioScrip, Inc., any security holder of BioScrip, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges forth in this footnote.
( 3)  Unvested

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bogusz Patricia
100 CLEARBROOK ROAD
ELMSFORD, NY 10523

Vice President, Finance

Signatures
/s/ Patricia Bogusz 5/17/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse BioPlus Acquisition
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse BioPlus Acquisition